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How does conformational flexibility influence
key structural features involved in activation of
anaplastic lymphoma kinase?†
Tatyana G. Karabencheva,*a Christian C. Lee,b Gary W. Black,a Rossen Donevc and
Christo Z. Christov*a
Anaplastic Lymphoma Kinase (ALK) plays a major role in developing tumor processes and therefore
has emerged as a validated therapeutic target. Applying atomistic molecular dynamics simulations on
the wild type enzyme and the nine most frequently occurring and clinically important activation mutants
we revealed important conformational effects on key interactions responsible for the activation of
the enzyme.
Introduction
Anaplastic Lymphoma Kinase (ALK) is a member of the insulin
receptor tyrosine kinase superfamily that normally participates in
the development of the nervous system in embryos, the expres-
sion of which decreases after birth.1,2 Twenty diﬀerent ALK-
fusion proteins resulting from diﬀerent chromosomal rearrange-
ments have been shown to be connected with the pathogenesis of
diseases such as anaplastic large-cell lymphoma, diﬀuse large
B-cell lymphoma and inflammatory myofibroblastic tumors.3
A series of germline and somatic single nucleotide polymorph-
isms in the catalytic domain of ALK were characterized recently
from neuroblastoma patient samples andmany were shown to be
related with deregulation of ALK and its constitutive activation.4–6
Recently resolved crystal structures of the wild type enzyme,7 its
complexes with adenosine diphosphate (ADP), and staurosporine
(STU),7 adenosine triphosphate (ATP) competitive inhibitors –
PHA-E429, NVP-TAE6848 and of two activation mutants9 revealed
a canonical protein kinase domain fold and topology. The
molecule is built of a smaller N-terminal lobe and a larger
C-terminal lobe (Fig. 1).7 The N-terminal lobe contains five
stranded antiparallel b-sheets, an important regulatory aC-helix
which can be in active and inactive positions and an ATP-binding
glycine-rich loop (P-loop). The juxtamembrane segment of the
N-terminus forms a b-turn motif which is unique for ALK. The
C-terminal lobe contains eight a-helices (aD–aI) and two b
stranded sheets. The activating loop (A-loop) which contains
residues 1270–1299 is located here and starts with a DFG-motif,
followed by a short aA-helix and ends with a Pro-Pro-Glu motif.
The catalytic loop is located between aE and the first strand of the
b-sheet in the C-lobe. The aA-helix is located below and ortho-
gonally to the aC-helix and against the N-terminal b-turn by
multiple polar and hydrophobic interactions.
The crystal structures display several features of inactive kinase
conformation such as the degree of lobe closure between N- and
Fig. 1 Structure of ALK (3L9P.pdb7). The a-helices are shown in purple,
the b-sheets are shown in yellow, and the 3–10 helices are shown in blue,
the loops are shown in cyan and the coils in white shown in red.
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C-terminal lobes, the position of the aC helix and its orientation
with respect to the C-lobe and the location of the distal part of the
A-loop which obstructs the peptide binding site. The structure does
not possess, however, all the negative regulatory elements that exist
in the insulin receptor kinases. The A-loop is in an intermediate
position between the inactive and active kinases and its proximal
part does not block the ATP-binding site as in other inactive kinase
conformations. The DFG-motif exhibits a ‘‘DFG-in’’ conformation as
in the case in the active kinases, and the aC-helix allows the proper
positioning of Glu1167 with Lys1150 for salt-bridge formation,
which is also typical for the active conformation.7
ALK activation involves complex changes in several structural
features and interactions including but not limited to the mutual
orientation of the aC and aA helices, the position of the A-loop, the
hydrogen bond between Tyr1278 and Cys1097 from the N-terminal
b-turn which locks the inactive conformation and the salt bridge
between Glu1167 and Lys1150 which is distinctive for the active
conformations.1,7 Lack of insights into conformational dynamics is
a major limitation of X-ray protein crystal structures as they are
largely static in nature and reflect some of the details of the
experimental methodology, such as ensemble and time averaged
properties, imposition of crystal packing eﬀects, and some devia-
tions due to the non-linearity of the registered signals and methods
of interpretation.10 Most importantly, crystal structures could miss
some important information about the conformational dynamics
and relaxation which are fundamental protein properties.11,12 The
delicate interactions which define such unique intermediate con-
formations would be influenced by the internal conformational
flexibility under native conditions; therefore exploration using mole-
cular dynamics (MD) is important in order to complement the
crystallographic structural information. In addition the correlation
between the protein dynamics in enzyme catalysis is mater of
intensive studies investigations and discussions.13–16 Recently
molecular dynamics study of the on the crizotinib resistance
mechanism of C1156Y mutation in ALK was carried on (ref. 17)
demonstrating the potential of molecular dynamics to investigate
atomistic effects of mutations, however it was carried on only for
15 ns and one mutation only.
The focus of our study is to establish whether the structure
of ALK, revealed by crystallographic studies as an intermediate
between the active and inactive conformations, is altered by the
conformational flexibility and to define the interactions responsible
for this. To achieve this insight we carried out a comprehensive set
of atomistic molecular dynamics (MD) Simulations followed by
detailed analysis of the time evolution and flexibility of multiple
interactions representative for both the inactive and active ALK
conformations. Here we discuss the influence of the conformational
flexibility of the key structural features of the inactive and active
conformations whilst the more comprehensive structure/mobility/to
activity relationship would be an objective of further project.
Methods
The MD simulations were carried out with the GROMACS
code (version 4.3.1)18 and Gromos43b1 force field for
100 nanoseconds (ns). Twelve MD simulations were carried
out for the wild-type apoenzyme ALK, ALK–ADP complex, ALK–
staurosporine complex and nine activation mutations –
M1166R, I1171N, F1174L, F1245C, I1250T, G1128A, T1151M,
R1192P and R1275Q.4–6 The system was prepared from the
following crystal structures of ALK taken from PDB19 as follows:
for the wild type free ALK MD simulation 3L9P.pdb structure
was used;7 for the ALK–ADP complex the 3LCT.pdb structure
which contains the ligand ADP was used;7 for ALK–staurosporine
complex, 3LCS.pdb structure which contains the inhibitor
staurosporine was used;7 for the nine simulations of the
activation mutant forms of the free ALK the 3L9P.pdb structure
was used from which all nine structures of activation mutations
were prepared from the crystal structure of the wild-type
enzyme using the ‘‘What if’’ web interface (http://swift.cmbi.
ru.nl/servers/html/index.html).20 In all simulations the missing
residues in the crystal structures of ALK were added using
PyMol.21 Gromacs utilities for system preparation were used
thoroughly. The hydrogen atoms were added according the
protonation states of the ionogenic groups and consequently
minimized. Gromos43a1 force field was thoroughly applied.
The ADP and staurosporine parameters were generated using
PRODRG web-based tool.22 Subsequently the entire system was
minimized using the steepest descent algorithm. The system
was then solvated using rectangular SPC23 water box placed
10 Å from the edges of the protein and neutralized. The solvent
was then equilibrated for 50 picoseconds (ps) at 310 K using
NVT ensemble. Production MD simulations were run for 100 ns
in NPT ensemble at 310 K applying Berendsen thermostat24
treating the electrostatic interactions by particle mesh Ewald
method.25 The simulation step was 2 fs and nonbonding
cutoff of 14 Å was applied. The simulation system is presented
on Fig. 2.
The quality of the simulations was assessed by Root Mean
Square Deviation (RMSD) (Fig. S1–S3A–I, ESI†), root mean






















































































This journal is©The Royal Society of Chemistry 2014 Mol. BioSyst.
square fluctuation (Fig. 3 in the main text and Fig. S4A–D and
S5A–D in ESI†), radius of gyration and total, kinetic and
potential energy values long the time of the simulation (the
plots are available from the authors by request). All calculations
were done for the aC atoms in reference to the initial mini-
mized structure. The stability of hydrogen bonds during the
simulations was assessed using Gromacs g_hbond utility. After
that the average number of the hydrogen bonds between
particular couples of residues per MD trajectory was extracted.
Salt-bridge distances were calculated using g_salt utility and
the averaged value for a particular couple of residues was
calculated for each trajectory. Several hydrophobic interactions
were calculated by g_dist command. The cluster analysis was
done using cutoff distance of 0.25 nm and the central structure
of the largest cluster was used for comparison with the mini-
mized crystal structure.
Results and discussion
The N-terminal b-turn, followed by the glycine-rich (P-loop) and
the A-loop (Fig. 3) exhibit high flexibility in the wild type free
enzyme (based on the RMSF values) which suggest that during
the process of activation they would undergo sensitive changes.
In the simulations of the structures with activation mutants the
N-terminal b-turn is characterized with higher flexibility than
the wild type enzyme in all mutants with the exception of
I1171N and T1151M (Fig. S5 in ESI†). The flexibility of the
A-loop is also increased by the activating mutations (with excep-
tion of G1128A). The P-loop is characterized with increased
flexibility in five mutants (I1250T, R1275Q, M1166R, R1192P
and T1151M). The N-terminal b-turn, glycine-rich (P-loop) and
the A-loop which are very flexible in the wild type enzyme and as
a result of the activating mutations their flexibility is increased
even more. The binding of ADP and staurosporine does not
influence the flexibility of the catalytic loop, aA- and aC-helices
(Fig. S4 in the ESI†) but (especially the binding of staurosporine)
leads to increased flexibility of the P-loop and the A-loop
(excluding the aA-helix).
The orientation between the aC- and aA-helices which is in is
key importance for switching between the inactive and active
conformations is stabilized by hydrogen bonds and electrostatic
interactions (Fig. 4). An insight about the orientation of the aA
and aC helices is provided by analysis of the hydrogen bonding
and electrostatic interactions between them (Tables 1 and 2).
The hydrogen bond between the side chain of Arg1275 and the
carbonyl oxygen of Asp1163 is presented in 60% and 70% from
the MD trajectories of T1151M and R1275Q mutants, 40% in the
wild type enzyme and the F1245C, I1250T, I1171N mutants and
with lower frequency in the G1128A, M1166R and F1174L.
Arg1279 interacts with Asp1163, as in the crystal structure, which
is indicated by both the hydrogen bonding profile and the salt-
bridged distance but this interaction tends to become less
strong. In the wild type Arg1275 and Glu1167 still interact
electrostatically and by a hydrogen bond, however in most of
the mutant forms, this hydrogen bond is presented with lower
frequency. The hydrogen bond between Arg1279 and Gln1159 is
stable in the MD trajectory of the wild type ALK and is presented
with diﬀerential stability in the mutants (e.g. it is relatively stable
in FF1174L and T1151M but is missing in G1128A and R1275Q).
The side chain of Asp1276 rotates towards the C-lobe during
the simulation and the hydrogen bond between Arg1275 and
Asp1276, which exists in the crystal structure, is not presented
in the simulation of the wild type and mutant forms (the
averaged distance between the side chains is higher than in
the crystal structure; 4.2 Å compared to 2.0 Å for the wild type
and even large diﬀerences in the mutant forms). The hydrogen
bond between Lys1285 from the A-loop and the aC-helix residue
Asp1163, disappears during the simulation of the wild type and
all activation mutant enzyme forms and Lys1285 moves away
from the aC-helix, due to the flexibility of the A-loop. The
repulsive interactions between the side chains of Arg1275 and
Fig. 3 RMSF values of the wild type free enzyme.
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Arg1279 with the side chain of Lys1285 might also contribute
to this eﬀect. The balance between these repulsive inter-
actions and the attractive interactions between the side chains
of Lys1285 and Asp1163, Asp1160, Glu1167 and Asp1276,
together with the high flexibility of the A-loop, can be a
controlling instrument for the positioning of the distal part
of the A-loop in more active-like orientation and thus postulated
to be part from the activation mechanism. The hydrogen bond-
ing and electrostatic interactions between aC and aA helices
become less strong and many of them partly or almost disappear
during the simulations of the wild type and mutant forms. This
could be an initial step from more long-range process of
reorientation of the aC and aA helices as a part from the enzyme
activation.
An important interaction that locks the aC helix in inactive
conformation is the hydrogen bond between Tyr1278 from the
A-loop (the preferred tyrosine residue for the autophosphoryla-
tion reaction), and Cys1097, from the N-terminal b-turn. It is
stable during 60% of the wild type ALK MD simulation and is
also observed with diﬀerent frequency in F1174F, I1171N,
R1275Q and F1245C but missing in F1245C, G1128A, I1250T,
M1166R and T1151M trajectories (Table 1 in the main text and
Table S1 in the ESI†) which suggest that the activation eﬀect of
this mutants might involve change of the orientation between
the N-terminal b-turn and aC helix.
Importantly, the hydrogen bond between the second A-loop
tyrosine Tyr1282 and Arg1284 also almost disappears in the
simulations of the wild type and the mutant forms of the enzyme
which also might be part from the initiation events of the activa-
tion. This could be facilitated by the flexibility of the A-loop and the
stronger interactions between the side chains of Arg1284 and
Glu1303 and between the side chains of Tyr1282 and Arg1248.
In contrast the hydrogen bond, representative for the inactive
conformation between the peptide backbones of DFG + 1 residue
Met1273 and Ile1277 that exists in the crystal structure is preserved
over the simulation with very high frequency and is also present in
all activationmutants. The existence of this interaction in ALK is in
contrast to all known active kinases.
Distinctive interaction for the active kinases conformations
is the salt bridge between Lys1150 and Glu1167. It is stronger
than in the crystal structure during the simulation of the wild
type enzyme and even much stronger in all mutant forms
(Table 1) which indicate that the structure became more
active-like regarding this interaction.
The comparison between the minimized crystal structure
and the central structure of the most populated cluster (Fig. 5)
Table 1 Averaged number of hydrogen bonds from the MD trajectories of the wild type apoenzyme ALK and all activation mutants
H-bond Cryst. struct. Wild type F1174L F1245C G1128A I1250T I1171N M1166R R1275Q T1151M
R1275-D1163 1 0.4 0.2 0.4 0.3 0.4 0.4 0.3 0.7 0.6
R1279-D1163 1 1.6 1.4 1.4 0.4 1.1 1.6 1.0 1.2 1.5
R1275-E1167 1 0.8 0.5 0.5 0.6 0.9 0.4 0.4 0 0.5
K1285-D1163 1 0 0 0 0 0 0 0 0 0
D1285-D1160 0 0 0 0 0 0 0 0 0 0
K1285-E1167 0 0 0 0 0 0 0 0 0 0
D1276-R1275 1 0 0 0 0 0 0.3 0 0 0
R1279-Q1159 1 0.7 0.8 0.5 0 0.6 0.5 0.4 0 0.9
Y1278-C1097 1 0.6 0.5 0.2 0 0 0.7 0 0.7 0
Y1282-R1284 1 0.1 0 0 0 0 0 0.1 0.2 0
K1150-E1167 0 0 0.5 0.6 0 0.5 0 0.5 0.3 0.9
R1275-R1248 0 0 0 0 0 0 0 0 0 0
D1276-R1248 0 0 0 0 0 0 0 0 0 0
R1248-I1246 0 0.2 0 0 0 0.1 0 0 0 0.3
M1273-R1248 0 0 0 0 0 0 0 0 0 0
M1273-I1277 1 0.98 0.8 0.9 0.7 0.8 1.0 0.9 1.0 0.8
H1247-G1269 0 0.1 0.3 0 0 0 0 0 0 0
Table 2 Averaged electrostatic interactions in the wild type and the activation mutant forms of the free ALK
Interact Cryst. struct. Wild type F1174L F1245C G1128A I1250T I1171N M1166R R1275Q T1151M
R1275-D1163 3.3 2.95 3.3 3.1 3.0 2.8 3.3 3.1 5.8 2.7
R1279-D1163 2.1 2.2 2.5 2.4 4.0 2.5 2.2 2.8 2.3 2.2
R1275-E1167 1.9 2.4 2.6 2.7 2.5 2.3 2.7 2.8 6.3 2.9
K1285-D1163 2.6 13.6 11.5 12.2 7.8 11.0 8.6 9.1 11.6 10.0
D1285-D1160 4.4 15.7 13.5 15.4 9.3 12.4 7.9 9.4 13.0 11.6
K1285-E1167 9.2 17.4 16.4 16.7 13.3 14.8 10.3 10.7 11.4 14.3
D1276-R1275 1.99 4.2 4.8 4.3 4.4 4.9 3.2 3.9 5.2 4.5
R1279-Q1159 6.6 6.6 7.4 7.1 9.2 6.95 6.7 7.3 8.96 6.9
Y1278-C1097 6.4 6.4 7.1 7.7 5.8 7.0 6.3 8.9 6.4 8.3
Y1282-R1284 6.8 6.8 6.94 6.7 5.9 6.8 7.9 6.7 5.7 8.8
K1150-E1167 4.7 3.2 2.5 2.5 2.7 2.5 2.9 2.5 2.9 2.2
R1275-R1248 10.5 10.0 12.0 12.1 12.6 11.5 12.1 11.7 10.8 10.6
D1276-R1248 9.7 9.7 9.8 9.7 11.5 9.0 10.2 9.7 9.8 7.9
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from the simulation of the wild type enzyme confirms that the
A-loop moved more towards the active position, which is more
expressed in its distal part during the simulation, and the
P-loop moved more towards the catalytic loop, whilst the
inter-lobe did not change considerably during the simulation.
Two interactions might be related to the positioning of the
P-loop closer to the catalytic loop. The salt bridge between
Lys1150 and Glu1167, which is characteristic for the active
conformation, is strengthen during the MD simulation of the
wild type and all mutants. In addition Arg1120 switches
between two glutamate residues – Glu1132 and Glu1129.
The results provide important insight revealing that numer-
ous interactions undergo initial changes relevant to the activa-
tion, namely: the hydrogen bonds and electrostatic interactions
which keep the inactive orientation between aC and aA helices
are less strong than in the crystal structure as well as the
hydrogen bond between the aC-helix to the N-terminal b-turn;
the A-loop is displaced in the more active position due to the
repulsive interactions between Lys1285 with Arg1275 and
Arg1279. Essentially, the salt-bridge between Glu1167 and
Lys1150 which is characteristic for the active conformation is
strengthened and might help for displacing of the P-loop
towards the catalytic loop. The N-terminal b-turn which is
unique for ALK exhibits high flexibility in the wild type ALK
and all mutant forms. The activating mutations tend to
increase even more the conformational flexibility with most
profound eﬀect of the A-loop and N-terminal b-turn and the
P-loop confirming their role during the activation process. The
complex process of activation might be initiated by several
events such as loosening the electrostatic interactions and
hydrogen bonding between the aC- and aA-helices, increasing
the flexibility of the A-loop and displacing it in a more active
position; increasing the flexibility of the N-terminal b-turn in
combination with the loosening and breaking of the ‘‘inactive
conformation’’ hydrogen bond between Tyr1278 and Cys1097,
strengthening the ‘‘active conformation interaction’’ between
Glu1167 and Lys1150; and displacing of the P-loop towards the
active site. The gained atomistic insight can be used for further
atomistic and mechanistic studies and as a background in
designing more eﬀective ALK inhibitors as potential drugs.
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